Molecular Cancer Therapeutics
Q1 Journal
Journal
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Cancer Research
Q1
└
Oncology
Q1
SJR 2025
2.392
Q1
SJR Score
H-Index
212
Citations / Doc (2yr)
5.55
Total Docs. (latest)
155
Total Citations (3yr)
2,514
Publication type
Journals
ISSN
15357163, 15388514
Coverage
2001-2026
Journal Rank
#1,046
Subject Categories
Cancer Research
Q1
Oncology
Q1
Subject Areas
Aims & Scope
Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology.
The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research.
Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Medline
Embase
Detailed Metrics
| Total Docs. (latest) | 155 |
| Total Docs. (3 years) | 433 |
| Total Refs. | 8,459 |
| Total Citations (3 years) | 2,514 |
| Citable Docs. (3 years) | 425 |
| Citations / Doc. (2 years) | 5.55 |
| Ref. / Doc. | 54.57 |
| % Female | 43.0% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.